Category: COVID-19/Coronavirus
COVID-19/Coronavirus market research reports by Kalorama Information
-
The Market and Future Potential for Molecular Point of Care
The Market and Future Potential for Molecular Point of Care This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies s ... Read More
-
Vaccines 2020: World Market Analysis, Players, Trends
Vaccines 2020: World Market Analysis, Players, Trends This report examines the market for these vaccines used to prevent various types of disease, and provides market modeling by disease. It focuses on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventab ... Read More
-
Molecular Diagnostics Markets in The COVID-19 Era
Molecular Diagnositcs Markets in The COVID-19 Era Now more than ever, molecular diagnostics are the most important part of in vitro diagnostics. Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for molecular diagnostics in all major s ... Read More
-
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment. Especially in oncology, companion diagnostics are ... Read More
-
Emerging Infectious Disease Diagnostics: Markets and Trends
Emerging Infectious Disease Diagnostics: Markets and Trends Why is it important to examine the world of emerging infectious diseases? In a 2015 TED Talk, Microsoft creator Bill Gates warned that there was a lack of preparation for a viral epidemic. He predicted that it would be “microbes, not missil ... Read More
-
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of ... Read More
-
Outsourcing in Drug Discovery, 9th Edition
Outsourcing in Drug Discovery, 9th Edition Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also imp ... Read More
-
Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline
Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, compani ... Read More
-
Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas
Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current C ... Read More
-
The Market and Future Potential for Molecular Point of Care
The Market and Future Potential for Molecular Point of Care This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies s ... Read More
Research Assistance
